US EditionBlue states call on FDA to expand abortion pill access
- Four states, led by California, petitioned the FDA to lift restrictions on mifepristone, arguing that the current regulations hinder access to safe prescriptions in primary care settings despite its proven safety record.
- California Attorney General Rob Bonta stated that the REMS program's restrictions on mifepristone are medically unjustified and burdensome, impacting access for women, especially in underserved areas.
- The petition emphasizes that no new scientific evidence has emerged to justify further restrictions, reaffirming mifepristone’s safety and effectiveness as critical healthcare for millions.
- Attorney General Letitia James of New York emphasized that there is no scientific reason to keep mifepristone under such restrictions, noting its 25-year safety record.
26 Articles
26 Articles
AG pushes back on federal abortion medication restrictions
BOSTON (SHNS) - Attorney General Andrea Campbell implored federal regulators Thursday to eliminate medication abortion restrictions on prescribers and pharmacies, arguing Massachusetts already has "robust" guardrails in place to protect patient safety. Campbell, along with AGs from California, New York and New Jersey, want the U.S. Food and Drug Administration to eliminate its Risk Evaluation and Mitigation Strategy (REMS) program for mifepristo…
US states urge Food and Drug Administration to expand abortion pill accessibility
The attorneys general of New York, California, Massachusetts, and New Jersey on Thursday asked the US Food and Drug Administration (FDA) to remove some of the restrictions on access to mifepristone, the so-called “abortion pill.” The four states have requested that the FDA remove the mifepristone risk evaluation and mitigation strategies (REMS) program, “including but not limited to the Prescriber Certification, Pharmacy Certification, and Patie…
Journalists Recap State of NIH Cancer Research and Abortion Law's Effect on Clinical Decisions
KFF Health News chief Washington correspondent Julie Rovner discussed Trump administration cuts to the National Institutes of Health on WNYC’s “The Brian Lehrer Show” on June 3. Click here to hear Rovner on “The Brian Lehrer Show.” KFF Health News Southern correspondent Sam Whitehead discussed Georgia’s abortion laws on WUGA’s “The Georgia Health Report” on May 30. Click here to hear Whitehead on “The Georgia Health Report.” KFF Health News is…
Four States Urge FDA to Follow Science and Remove Abortion Pill Restrictions
Attorneys general of four states—Massachusetts, California, New Jersey and New York—asked the U.S. Food and Drug Administration (FDA) on Thursday, June 5, to lift long-standing restrictions on the medication mifepristone. The drug is used in approximately two-thirds of abortions in the United States. The petition came just three days after the FDA commissioner Marty Makary announced his decision to “review” the agency’s regulation of mifepriston…
LifeNews.com
littlebytesnews.comDemocrat AGs Push for Abortion on Demand With No Limits
Three days after FDA Commissioner Marty Makary promised to “closely monitor the post-marketing safety data on mifepristone for the medical termination of early pregnancy” and a week after National Right to Life wrote Commissioner Makary urging him to reexamine “studies not sponsored by the abortion industry,” four Democrat-led states asked the FDA to remove what pitifully weak “limitations” still exist. The attorneys general of California, New Y…
Coverage Details
Bias Distribution
- 52% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
